आधिकारिक वित्तीय विवरणों से राजस्व, लाभ और नकदी प्रवाह का इतिहास.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest.
इंटरैक्टिव चार्ट और पूर्ण वित्तीय विवरण देखें → वैल्यूएशन मॉडल (DCF) →
| आय विवरण | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| कुल राजस्व | $4.4B | $4.3B | $4.4B | $4.5B | $4.6B | $4.5B | $3.2B | $3.5B | $3.3B | $2.8B | $2.4B | $2.2B | $1.9B | $1.4B | $1.1B | $1.1B | $903M | $666M | $573M | $367M | $185M |
| सकल लाभ | $2.9B | $2.9B | $2.9B | $2.7B | $3.0B | $3.2B | $2.2B | $2.5B | $2.3B | $1.8B | $1.7B | $1.5B | $1.3B | $912M | $774M | $709M | $602M | $461M | $368M | $234M | $125M |
| सकल मार्जिन % | 67.1% | 66.7% | 65.4% | 60.9% | 64.8% | 69.7% | 68.0% | 69.6% | 69.0% | 66.3% | 69.5% | 69.8% | 69.7% | 64.2% | 67.3% | 67.2% | 66.6% | 69.1% | 64.1% | 63.9% | 67.8% |
| परिचालन लाभ (EBIT) | $919M | $864M | ($833M) | ($1.1B) | ($4.2B) | ($123M) | $393M | $985M | $883M | $606M | $587M | $613M | $515M | $134M | $201M | $199M | $212M | $126M | $80M | ($301M) | $38M |
| परिचालन मार्जिन % | 20.9% | 19.9% | -19.1% | -23.7% | -91.2% | -2.7% | 12.1% | 27.8% | 26.5% | 22.0% | 24.5% | 27.6% | 27.7% | 9.4% | 17.5% | 18.9% | 23.4% | 18.9% | 14.0% | -82.1% | 20.5% |
| शुद्ध लाभ | $853M | $850M | ($1.2B) | ($1.2B) | ($4.4B) | $762M | $656M | $1.0B | $826M | $726M | $463M | $462M | $353M | $125M | $151M | $87M | $125M | $72M | $50M | ($278M) | $40M |
| शुद्ध मार्जिन % | 19.4% | 19.6% | -28.0% | -25.8% | -96.1% | 16.8% | 20.2% | 28.3% | 24.8% | 26.4% | 19.3% | 20.8% | 19.0% | 8.8% | 13.2% | 8.2% | 13.8% | 10.8% | 8.8% | -75.9% | 21.6% |
| EBITDA | $1.4B | $1.5B | ($725M) | ($1.1B) | ($3.8B) | $128M | $580M | $1.2B | $1.1B | $762M | $735M | $753M | $603M | $297M | $326M | $237M | $252M | $169M | $123M | $18M | $44M |
| प्रति शेयर आय (EPS) | $5.51 | $5.45 | $-7.69 | $-7.35 | $-28.05 | $5.05 | $4.43 | $6.72 | $5.54 | $4.91 | $3.13 | $3.10 | $2.37 | $0.90 | $1.13 | $0.62 | $0.87 | $0.53 | $0.38 | $-2.57 | $0.41 |
| बकाया शेयर (मिलियन) | 154M | 156M | 159M | 158M | 157M | 151M | 148M | 149M | 149M | 148M | 148M | 149M | 149M | 140M | 134M | 139M | 143M | 137M | 134M | 108M | 98M |
स्रोत: कंपनी की सार्वजनिक रिपोर्टें (SEC). किसी भी आँकड़े पर भरोसा करने से पहले SEC EDGAR पर उसकी पुष्टि करें.
बैलेंस शीट, नकदी प्रवाह, तिमाही आँकड़े और सभी वित्तीय अनुपात ILMN के इंटरैक्टिव व्यूअर में उपलब्ध हैं. /companies/us/ILMN
इस वेबसाइट की जानकारी केवल शैक्षिक और सूचनात्मक उद्देश्यों के लिए है और निवेश सलाह नहीं है. कोई मूल्य लक्ष्य या सिफ़ारिश प्रकाशित नहीं की जाती.
About TickerBase · Data methodology & sources · Privacy · Terms